Synthesis of indirubin-N′-glycosides and their anti-proliferative activity against human cancer cell lines

被引:52
作者
Libnow, Stefanie [1 ]
Methling, Karen [2 ]
Hein, Martin [1 ]
Michalik, Dirk [3 ]
Harms, Manuela [2 ]
Wende, Kristian [2 ]
Flemming, Anke [1 ]
Koeckerling, Martin [1 ]
Reinke, Helmut [1 ]
Bednarski, Patrick J. [2 ]
Lalk, Michael [2 ]
Langer, Peter [1 ,3 ]
机构
[1] Univ Rostock, Inst Chem, D-18059 Rostock, Germany
[2] Ernst Moritz Arndt Univ Greifswald, Inst Pharm, D-17487 Greifswald, Germany
[3] Univ Rostock, Leibniz Inst Katalyse eVan, D-18059 Rostock, Germany
关键词
anti-proliferative activity; carbohydrates; N-heterocycles; indirubin;
D O I
10.1016/j.bmc.2008.04.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The first indirubin-N'-glycosides were prepared based on reactions of isatin-N'-glycosides with indoxyls. The products show a significant anti-proliferative activity against various human cancer cell lines. Good results were observed for an indirubin-N'- mannoside which was shown to have medium to high anti-proliferative activity against all investigated cell lines. The highest activities and selectivities against the MCF-7 breast cancer cell line were observed for indirubin-N'-rhamnosides. (C) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5570 / 5583
页数:14
相关论文
共 33 条
[1]
Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine [J].
Adachi, J ;
Mori, Y ;
Matsui, S ;
Takigami, H ;
Fujino, J ;
Kitagawa, H ;
Miller, CA ;
Kato, T ;
Saeki, K ;
Matsuda, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31475-31478
[2]
Synthesis of novel 5-substituted indirubins as protein kinases inhibitors [J].
Beauchard, Anne ;
Ferandin, Yoan ;
Frere, Stephane ;
Lozach, Olivier ;
Blairvacq, Melina ;
Meijer, Laurent ;
Thiery, Valerie ;
Besson, Thierry .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (18) :6434-6443
[3]
Correlations between the activities of 19 anti-tumor agents and the intracellular glutathione concentrations in a panel of 14 human cancer cell lines:: comparisons with the National Cancer Institute data [J].
Bracht, K ;
Boubakari ;
Grünert, R ;
Bednarski, PJ .
ANTI-CANCER DRUGS, 2006, 17 (01) :41-51
[4]
NMR-STUDIES OF D-RIBOSYLAMINES IN SOLUTION - DERIVATIVES OF PRIMARY AMINES .1. [J].
CHAVIS, C ;
DEGOURCY, C ;
DUMONT, F ;
IMBACH, JL .
CARBOHYDRATE RESEARCH, 1983, 113 (01) :1-20
[5]
Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest [J].
Damiens, E ;
Baratte, B ;
Marie, D ;
Eisenbrand, G ;
Meijer, L .
ONCOGENE, 2001, 20 (29) :3786-3797
[6]
Inhibitor binding to active and inactive CDK2: The crystal structure of CDK2-cyclin A/indirubin-5-sulphonate [J].
Davies, TG ;
Tunnah, P ;
Meijer, L ;
Marko, D ;
Eisenbrand, G ;
Endicott, JA ;
Noble, MEM .
STRUCTURE, 2001, 9 (05) :389-397
[7]
Inhibition of cyclin-dependent kinases by purine analogues - Crystal structure of human cdk2 complexed with roscovitine [J].
DeAzevedo, WF ;
Leclerc, S ;
Meijer, L ;
Havlicek, L ;
Strnad, M ;
Kim, SH .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1997, 243 (1-2) :518-526
[8]
Plasmodium falciparum glycogen synthase kinase-3:: molecular model, expression, intracellular localisation and selective inhibitors [J].
Droucheau, E ;
Primot, A ;
Thomas, V ;
Mattei, D ;
Knockaert, M ;
Richardson, C ;
Sallicandro, P ;
Alano, P ;
Jafarshad, A ;
Baratte, B ;
Kunick, C ;
Parzy, D ;
Pearl, L ;
Doerig, C ;
Meijer, L .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2004, 1697 (1-2) :181-196
[9]
Cyclin-dependent kinase inhibitor indirubin-3′-oxime selectively inhibits human papillomavirus type 16 E7-induced numerical centrosome anomalies [J].
Duensing, S ;
Duensing, A ;
Lee, DC ;
Edwards, KM ;
Piboonniyom, SO ;
Manuel, E ;
Skaltsounis, L ;
Meijer, L ;
Münger, K .
ONCOGENE, 2004, 23 (50) :8206-8215
[10]
Grese TA, 1996, ANNU REP MED CHEM, V31, P181